Cargando…

X-ray Absorption Near Edge Structure Spectroscopy to Resolve the in Vivo Chemistry of the Redox-Active Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019)

[Image: see text] Indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (1, KP1019) and its analogue sodium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (2, KP1339) are promising redox-active anticancer drug candidates that were investigated with X-ray absorption near edge structure spec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hummer, Alfred A., Heffeter, Petra, Berger, Walter, Filipits, Martin, Batchelor, David, Büchel, Gabriel E., Jakupec, Michael A., Keppler, Bernhard K., Rompel, Annette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2013
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579476/ https://www.ncbi.nlm.nih.gov/pubmed/23282017 http://dx.doi.org/10.1021/jm301648f

Ejemplares similares

X-ray Structure Analysis of Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) Bound to Human Serum Albumin Reveals Two Ruthenium Binding Sites and Provides Insights into the Drug Binding Mechanism
por: Bijelic, Aleksandar, et al.
Publicado: (2016)

Solvolysis of the Tumor-Inhibiting Ru(III)-Complex trans-Tetrachlorobis(Indazole)Ruthenate(III)
por: Pieper, Thomas, et al.
Publicado: (2000)

Electronic State of Sodium trans-[Tetrachloridobis(1H-indazole)ruthenate(III)] (NKP-1339) in Tumor, Liver and Kidney Tissue of a SW480-bearing Mouse
por: Blazevic, Amir, et al.
Publicado: (2017)

Inhibitory Effects of the Ruthenium Complex KP1019 in Models of Mammary Cancer Cell Migration and Invasion
por: Bergamo, A., et al.
Publicado: (2009)

En Route to Osmium Analogues of KP1019: Synthesis, Structure, Spectroscopic Properties and Antiproliferative Activity of trans-[Os(IV)Cl(4)(Hazole)(2)]
por: Büchel, Gabriel E., et al.
Publicado: (2011)

Osmium(IV) complexes with 1H- and 2H-indazoles: Tautomer identity versus spectroscopic properties and antiproliferative activity
por: Büchel, Gabriel E., et al.
Publicado: (2012)

DMSO reduces the cytotoxicity of anticancer ruthenium complex KP1019 in yeast
por: Davis, Jonathan, et al.
Publicado: (2021)

Synthesis, Characterization and Solution Chemistry of trans-Indazoliumtetrachlorobis(Indazole)Ruthenate(III), a New Anticancer Ruthenium Complex. IR, UV, NMR, HPLC Investigations and Antitumor Activity. Crystal Structures of trans-1-Methyl-Indazoliumtetrachlorobis-(1-Methylindazole)Ruthenate(III) and its Hydrolysis Product trans-Monoaquatrichlorobis-(1-Methylindazole)-Ruthenate(III)
por: Lipponer, Kari-Georg, et al.
Publicado: (1996)

DNA Damage Response Checkpoint Activation Drives KP1019 Dependent Pre-Anaphase Cell Cycle Delay in S. cerevisiae
por: Bierle, Lindsey A., et al.
Publicado: (2015)

Photostriction of strontium ruthenate
por: Wei, Tzu-Chiao, et al.
Publicado: (2017)

Correction: DNA Damage Response Checkpoint Activation Drives KP1019 Dependent Pre-Anaphase Cell Cycle Delay in S. cerevisiae
Publicado: (2015)

A systematic assessment of chemical, genetic, and epigenetic factors influencing the activity of anticancer drug KP1019 (FFC14A)
por: Golla, Upendarrao, et al.
Publicado: (2017)

The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo()
por: Heffeter, Petra, et al.
Publicado: (2013)

KP772 overcomes multiple drug resistance in malignant lymphoma and leukemia cells in vitro by inducing Bcl-2-independent apoptosis and upregulation of Harakiri
por: Kater, Lisa, et al.
Publicado: (2021)

NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
por: Alessio, Enzo, et al.
Publicado: (2019)

Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition
por: Kubista, Bernd, et al.
Publicado: (2017)

Adsorption of Water at the SrO Surface of Ruthenates
por: Halwidl, Daniel, et al.
Publicado: (2015)

Colossal negative thermal expansion in reduced layered ruthenate
por: Takenaka, Koshi, et al.
Publicado: (2017)

NKP-1339, a first-in-class anticancer drug showing mild side effects and activity in patients suffering from advanced refractory cancer
por: Trondl, Robert, et al.
Publicado: (2012)

Metal Ruthenate Perovskites as Heterogeneous Catalysts for the Hydrolysis of Ammonia Borane
por: Badding, Catherine K., et al.
Publicado: (2018)

First-Principles Correlated Approach to the Normal State of Strontium Ruthenate
por: Acharya, S., et al.
Publicado: (2017)

Tricyanidoferrates(−IV) and Ruthenates(−IV) with Non‐Innocent Cyanido Ligands
por: Jach, Franziska, et al.
Publicado: (2021)

Biological properties of novel ruthenium- and osmium-nitrosyl complexes with azole heterocycles
por: Novak, Maria S., et al.
Publicado: (2016)

Water-Splitting Electrocatalysis in Acid Conditions Using Ruthenate-Iridate Pyrochlores**
por: Sardar, Kripasindhu, et al.
Publicado: (2014)

Optimizing Strontium Ruthenate Thin Films for Near-Infrared Plasmonic Applications
por: Braic, Laurentiu, et al.
Publicado: (2015)

Ruthenate and rutheno-cuprate materials: unconventional superconductivity, magnetism and quantum phase transitions
por: Vecchione, A, et al.
Publicado: (2002)

Tetraethylammonium trichlorido(η(6)-p-cymene)ruthenate(II)
por: Wu, Fang-Hui, et al.
Publicado: (2009)

Quadruple perovskite ruthenate as a highly efficient catalyst for acidic water oxidation
por: Miao, Xianbing, et al.
Publicado: (2019)

Enhancement of ferromagnetism by oxygen isotope substitution in strontium ruthenate SrRuO(3)
por: Kawanaka, Hirofumi, et al.
Publicado: (2016)

Orbital ordering and magnetism in layered Perovskite Ruthenate Sr(2)RuO(4)
por: Huang, Hung-Lung, et al.
Publicado: (2020)

Organometallic indolo[3,2-c]quinolines versus indolo[3,2-d]benzazepines: synthesis, structural and spectroscopic characterization, and biological efficacy
por: Filak, Lukas K., et al.
Publicado: (2010)

Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo
por: d'Anglemont de Tassigny, Xavier, et al.
Publicado: (2017)

Ruthenation of Non‐stacked Guanines in DNA G‐Quadruplex Structures: Enhancement of c‐MYC Expression
por: Rodríguez, Jéssica, et al.
Publicado: (2016)

Obituary – Dr. KP Srivastava
por: Pruthi, KK
Publicado: (2017)

Asthma diagnosis and treatment – 1019. Churg Strauss Syndrome – missed diagnosis and consequences
por: Kamdar, Mahomed Cassim
Publicado: (2013)

PReS-FINAL-1019: Inflammatory monocytes induce resistance of effector t cells to suppression
por: Wehrens, EJ, et al.
Publicado: (2013)

The functional −1019C/G HTR1A polymorphism and mechanisms of fear
por: Straube, B, et al.
Publicado: (2014)

1019. The Future is Embedded in the Present - Characterizing Pharmacist Interventions in an Infectious Diseases Clinic
por: Depcinski, Shawn, et al.
Publicado: (2022)

Correction: Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo
por: d’Anglemont de Tassigny, Xavier, et al.
Publicado: (2018)

Synthesis of 2-Alkenyl-2H-indazoles from 2-(2-Carbonylmethyl)-2H-indazoles
por: Lin, Mei-Huey, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nrg6bpm3a79j9uugin8e5lbcok